Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alisertib in AT/RT and MRT
NCT02114229Phase 2Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- May 2014
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alisertib in Atypical teratoid rhabdoid tumor (ATRT), malignant rhabdoid tumor (MRT), sponsored by St. Jude Children's Research Hospital. Started May 2014; status: active, not recruiting.
02
Drugs
alisertib
03
Conditions
Atypical teratoid rhabdoid tumor (ATRT)malignant rhabdoid tumor (MRT)
Beyond the preview
Go deeper on NCT02114229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02114229.